Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Chemotherapy-Induced Hair Loss: Insights and Effective Strategies

Masonic Cancer Center, University of Minnesota

M. Hordinsky

Overview and Updates in Brain Tumors

Henry Friedman

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Best Practices for the Provider Approach in Treating Patients With I…

Katherine Peters

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Mohan

Effective Strategies for Managing IDH-Mutant Gliomas

Matteo Simonelli

Diagnosing IDH-Mutant Diffuse Glioma: Recent Classification Updates …

Ashley Aaroe

ESMO 2024 Summary: Antibody Drug Conjugates (ADCs) - Identifying New…

2024 ESMO Annual Meeting Insights Hub

S. Banerjee

Surgical Approaches for Brain Tumors

Dana-Farber Cancer Institute

W. Linda Bi, O. Arnaout

ESMO 2024 Insights: Induction Chemo Followed by CRT in Advanced Cerv…

2024 ESMO Annual Meeting Insights Hub

G. Eminowicz

IDH-Mutant Diffuse Glioma: Best Practices for Multidisciplinary Appr…

Ruham Nasany

Medical and Symptom Management of Patients With Brain Tumors

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

A. Pruitt

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovora…

2024 ASCO® Annual Meeting Insights Hub

D. Ziegler